Search results for: 'china cell ad gene therapy industry development waste part'
- Did you mean
- china cell ad g01e therapy industry development waste pfrt
- china cell ad gene therapy industry development waste pfrt
- Related search terms
- Industry Report on high Value Specialty Steel, Super alloys and titanium Alloy Products Market in India
- Cell+and+gene+manufacturing
- industry conference impacting the global compressor market 2025
- industry conferenc impacting the global compressor market 2025
- industry convergence impacting the global compressor market 2024
-
20 Mar 2026  |  Global  |  Technology Research
Innovations in Waste-to-biofuels Technology, Genome Editing, Yeast-based Biosynthesis Technology, Smart Waste Management, Bioleaching, and Cryo-milling
Industrial Bioprocessing Technology Opportunity Engine
This edition of the Industrial Bioprocessing TOE features information on innovations in waste-to-biofuels technology, genetic engineering, yeast-based biosynthesis, smart waste management techniques, cryo-milling technology, aeration and emission control technology, among others.The Industrial Bioprocessing TOE provides intelligence on technologies...
$950.00 -
13 Jul 2026  |  Global  |  Technology Research
RNA Therapies in Rare Diseases
Proven clinical success pushing the development of RNA therapies in rare diseases
Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...
$4,950.00 -
19 Jun 2023  |  Global  |  Technology Research
Thermo-Chemical Waste Treatment Technologies Facilitate Sustainable Fuel Generation
Integrating TCWT Solutions into Industrial Processes Produces Specialty Chemicals and Fuels While Significantly Reducing Carbon Emissions
Globally, exponential population growth, rampant consumerism, and economic development are the major drivers of waste generation. The World Bank estimates that waste generation is going to increase from about 2.3 billion tons per year by 2023 to 3.4 billion tons per year by 2050. Out of the 2.3 billion tons of waste produced in 2023, as much as 33 ...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Apr 2018  |  Global  |  Market Outlook
Global Waste Recycling Market Outlook, 2018
Principles of Sustainability, Innovative Business Models, and Disruptive Technologies to Change the Landscape of Waste Recycling Market
Principles of sustainability, innovative business models, and disruptive technologies are likely to change the landscape of waste recycling market. This outlook study provides an overall update on the global waste recycling market in 2018, covering the municipal solid waste, industrial non-hazardous waste, WEEE, construction & demolition waste, and...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Dec 2022  |  Europe  |  Frost Radar
Frost Radar™: European Aftermarket Parts Distributors, 2022
A Benchmarking System to Spark Companies to Action ‒ Innovation That Fuels New Deal Flow and Growth Pipelines
The European aftermarket distribution ecosystem is a multi-billion euro industry, with distributors grouped into uneven clusters based on their size (revenue and network) and the operating structures of their respective buying groups. Frost & Sullivan independently plotted the top 10 European distributors in this Frost Radar™ analysis. In 2019, sel...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Feb 2026  |  Global  |  Technology Research
Breakthrough Innovations Leading to Commercialization of Organic Solar Cells
Technical Developments Advancing Organic Solar Cell Commercialization
Organic solar cells (OSCs) are emerging as one of the more versatile photovoltaic technologies inthe third-generation solar cell technology domain, owing to their unique characteristics of flexibility, ultralightweight form factors, low-temperature processing, and compatibility with high-throughput printing techniques. Advancements in donor–accepto...
$4,950.00 -
29 Jun 2015  |  Global  |  Technology Research
Trends in mammalian cell cultures
Technology Market Penetration and Roadmapping
With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Dec 2020  |  North America  |  Market Research
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market
Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential
This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Oct 2020  |  Global  |  Market Research
Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026
Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities
The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00
Special Price $3,712.50 save 25 %